Form 483

La Vita Compounding Pharmacy, LLC Form 483, 2020-03-11

FDA issued a Form 483 to La Vita Compounding Pharmacy, LLC on 2020-03-11 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

La Vita Compounding Pharmacy, LLC · San Diego, United States · Issued March 11, 2020

Overview

  • 4 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

11 Mar 2020
FDCA 501(a)(2)(A)

Actionable microbial contamination, adjacent area

Cited by Zachary A Bogorad, Nathaniel B Phillips Sylvain

11 Mar 2020
FDCA 501(a)(2)(A)

Cleanliness, ISO-classified areas

Cited by Zachary A Bogorad, Nathaniel B Phillips Sylvain

11 Mar 2020
FDCA 501(a)(2)(A)

Improper gowning, contamination

Cited by Zachary A Bogorad, Nathaniel B Phillips Sylvain

11 Mar 2020
FDCA 501(a)(2)(A)

Use of non-pharmaceutical grade components

Cited by Zachary A Bogorad, Nathaniel B Phillips Sylvain

Inspected site

LVLa Vita Compounding Pharmacy, LLCSan Diego, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations4x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere